Antibe Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

TSX:ATE Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Mar 24BuyCA$10,000Daniel LegaultIndividual20,000CA$0.50
07 Mar 24BuyCA$7,800Scott CurtisIndividual15,000CA$0.52
06 Mar 24BuyCA$12,970Joseph StaufferIndividual24,000CA$0.54

Insider Trading Volume

Insider Buying: ATE insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ATE?
Owner TypeNumber of SharesOwnership Percentage
Private Companies173,0890.327%
Institutions240,0000.453%
Individual Insiders1,636,4953.09%
General Public50,959,77896.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 8 shareholders own 3.87% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
2.13%
Daniel Legault
1,129,396CA$333.2k1.8%no data
0.48%
Joseph Stauffer
254,819CA$75.2k33.3%no data
0.45%
NFQ Ventures
240,000CA$70.8k0%no data
0.33%
The Elegen Group Inc
173,089CA$51.1k69%no data
0.22%
Scott Curtis
115,000CA$33.9k15%no data
0.13%
Alain Wilson
68,918CA$20.3k0%no data
0.079%
Ana Stegic
41,700CA$12.3k0%no data
0.05%
David Vaughan
26,662CA$7.9k0%no data